CHU Saint-Etienne
Saint-Etienne, France
NCT Number: NCT05880615
PostOperative Delirium (POD) is the most common neuropsychiatric complication following cardiac surgery and may be related to morphine consumption. PostOperative Delirium (POD) prolongs hospital and intensive care unit (ICU) length of stay (LOS) and increases morbidity and mortality. No study has been conducted to demonstrate the effect of regional anesthesia using catheters inserted before sternotomy.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Saint-Etienne, France
This study investigate the effect of an enhanced recovery protocol using regional anesthesia on PostOperative Delirium (POD) onset.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
collection of datas:
Time frame: Hours: 48
assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Delirium is diagnosed when criteria 1 and 2 are positive, as well as criteria 3 or 4.
Time frame: Hours: 48
Data collected in medical record: PaO2/FiO2 < 300
Time frame: Hours: 48
Data collected in medical record:absence of gas and/or material
Time frame: Hours: 48
Data collected in medical record
Time frame: Hours: 24, 48
Data collected in medical record
Time frame: Hours: 48
Data collected in medical record.
Time frame: Hours: 48
Data collected in medical record.
Time frame: Day: 30
Data collected in medical record.
Centre Hospitalier Universitaire de Saint Etienne
Other
Acronym: ORACAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05942183
Cardiac Disease, Cardiac Valve Disease
Samsun, Turkey (Türkiye)
View Trial DetailsNCT05628480
Cardiac Disease, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05490303
Cardiac Disease, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06154473
Arterial Occlusive Diseases, Arteriosclerosis
São Paulo, Brazil
View Trial Details